119 related articles for article (PubMed ID: 1292637)
1. IL-1 synergizes with ARA-C in aborting the development of chloroleukemia while protecting from ARA-C-induced alopecia in the rat model.
Jimenez JJ; Huang HS
Cytokine; 1992 Nov; 4(6):551-4. PubMed ID: 1292637
[TBL] [Abstract][Full Text] [Related]
2. Synergism of ara-C-imuvert combination in aborting the development of transplanted chloroleukemia in the rat.
Hussein AM; Jimenez JJ; Hindahl M; Yunis AA
Am J Med Sci; 1991 Feb; 301(2):81-4. PubMed ID: 2012104
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 1 protects hair follicles from cytarabine (ARA-C)-induced toxicity in vivo and in vitro.
Jimenez JJ; Sawaya ME; Yunis AA
FASEB J; 1992 Feb; 6(3):911-3. PubMed ID: 1740239
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 1 protects against 1-beta-D-arabinofuranosylcytosine-induced alopecia in the newborn rat animal model.
Hussein AM
Cancer Res; 1991 Jun; 51(12):3329-30. PubMed ID: 2040008
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment with 1,25(OH)2D3 protects from Cytoxan-induced alopecia without protecting the leukemic cells from Cytoxan.
Jimenez JJ; Alvarez E; Bustamante CD; Yunis AA
Am J Med Sci; 1995 Aug; 310(2):43-7. PubMed ID: 7631641
[TBL] [Abstract][Full Text] [Related]
6. Protection from 1-beta-D-arabinofuranosylcytosine-induced alopecia by epidermal growth factor and fibroblast growth factor in the rat model.
Jimenez JJ; Yunis AA
Cancer Res; 1992 Jan; 52(2):413-5. PubMed ID: 1728412
[TBL] [Abstract][Full Text] [Related]
7. Treatment with Imuvert aborts development of chloroleukemia in newborn rats.
Jimenez JJ; McCall CA; Cirocco RE; Yunis AA
J Biol Response Mod; 1990 Jun; 9(3):300-4. PubMed ID: 2380744
[TBL] [Abstract][Full Text] [Related]
8. Modulation of cytotoxicity and differentiation-inducing potential of arabinofuranosylcytosine in myeloid leukemia cells by hematopoietic cytokines.
Brach MA; Mertelsmann RH; Herrmann F
Cancer Invest; 1993; 11(2):198-211. PubMed ID: 8462021
[TBL] [Abstract][Full Text] [Related]
9. Effect of interleukin 3 on cytosine arabinoside-mediated cytotoxicity of leukemic myeloblasts.
Brach M; Klein H; Platzer E; Mertelsmann R; Herrmann F
Exp Hematol; 1990 Aug; 18(7):748-53. PubMed ID: 1696204
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of the cytotoxicity of cytosine arabinoside by interleukin-3.
Tanaka M
Jpn J Cancer Res; 1992 Feb; 83(2):194-9. PubMed ID: 1556000
[TBL] [Abstract][Full Text] [Related]
11. Protection against cytosine arabinoside-induced alopecia by minoxidil in a rat animal model.
Hussein AM
Int J Dermatol; 1995 Jul; 34(7):470-3. PubMed ID: 7591409
[TBL] [Abstract][Full Text] [Related]
12. The protective role of the immunomodulator AS101 against chemotherapy-induced alopecia studies on human and animal models.
Sredni B; Xu RH; Albeck M; Gafter U; Gal R; Shani A; Tichler T; Shapira J; Bruderman I; Catane R; Kaufman B; Whisnant JK; Mettinger KL; Kalechman Y
Int J Cancer; 1996 Jan; 65(1):97-103. PubMed ID: 8543404
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 1 protects from cytosine arabinoside-induced alopecia in the rat model.
Jimenez JJ; Wong GH; Yunis AA
FASEB J; 1991 Jul; 5(10):2456-8. PubMed ID: 2065892
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte-macrophage colony-stimulating factor and interleukin-3 enhance the incorporation of cytosine arabinoside into the DNA of leukemic blasts and the cytotoxic effect on clonogenic cells from patients with acute myeloid leukemia.
Hiddemann W; Kiehl M; Zühlsdorf M; Busemann C; Schleyer E; Wörmann B; Büchner T
Semin Oncol; 1992 Apr; 19(2 Suppl 4):31-7. PubMed ID: 1553573
[TBL] [Abstract][Full Text] [Related]
15. Combination of granulocyte colony-stimulating factor and low-dose cytosine arabinoside further enhances myeloid differentiation in leukemia cells in vitro.
Katagiri T; Miyazawa K; Nishimaki J; Yaguchi M; Kawanishi Y; Ohyashiki K
Leuk Lymphoma; 2000 Sep; 39(1-2):173-84. PubMed ID: 10975397
[TBL] [Abstract][Full Text] [Related]
16. Reversal of cytosine arabinoside (ara-C) resistance by the synergistic combination of 6-thioguanine plus ara-C plus PEG-asparaginase (TGAP) in human leukemia lines lacking or expressing p53 protein.
Fu CH; Martin-Aragon S; Weinberg KI; Ardi VC; Danenberg PV; Avramis VI
Cancer Chemother Pharmacol; 2001 Aug; 48(2):123-33. PubMed ID: 11561778
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous administration of granulocyte-macrophage colony-stimulating factor and cytosine arabinoside for the treatment of relapsed acute myeloid leukemia.
Cannistra SA; DiCarlo J; Groshek P; Kanakura Y; Berg D; Mayer RJ; Griffin JD
Leukemia; 1991 Mar; 5(3):230-8. PubMed ID: 1826536
[TBL] [Abstract][Full Text] [Related]
18. CSFs in combination with cytosine arabinoside, an inhibitor of DNA synthesis: potential strategies for the treatment of myeloid disorders.
Brach M; Stone R; Kufe D
Biotechnol Ther; 1991; 2(3-4):269-83. PubMed ID: 1845130
[TBL] [Abstract][Full Text] [Related]
19. Colony-stimulating factors (rhG-CSF, rhGM-CSF, rhIL-3, and BCGF) recruit myeloblastic and lymphoblastic leukemic cells and enhance the cytotoxic effects of cytosine-arabinoside.
Andreeff M; Tafuri A; Hegewisch-Becker S
Haematol Blood Transfus; 1990; 33():747-62. PubMed ID: 2323674
[TBL] [Abstract][Full Text] [Related]
20. Effects of bryostatin 1 and other pharmacological activators of protein kinase C on 1-[beta-D-arabinofuranosyl]cytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells.
Jarvis WD; Povirk LF; Turner AJ; Traylor RS; Gewirtz DA; Pettit GR; Grant S
Biochem Pharmacol; 1994 Mar; 47(5):839-52. PubMed ID: 8135859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
